Abstract Objective To investigate the clinical efficacy and safety of caffeine citrate and aminophylline in the treatment of primary apnea in premature infants. Methods The clinical data of 125 premature infants with primaryapnea from March 2013 to March 2014 were retrospectively analyzed. According to the therapeutic strategy, the patientswere divided into caffeine citrate group (n=65) and aminophylline group (n=60). The overall response rates and adversereaction rates in the two groups were compared. Results The overall response rate in the caffeine citrate group was 86% (56 cases), which was significantly higher than that in the aminophylline group (72%, 43 cases) (PPConclusions Caffeine citrate is more effective and causes feweradverse reactions than aminophylline in the treatment of primary apnea in premature infants.
Moriette G, Lescure S, EI Ayoubi M, et al. Apnea of prematurity:what's new[J]. Arch Pediatr, 2010, 17(2):186-190.
[2]
Janvier A, Khairy M, Kokkotis A, et al. Apnea is associated with neurodevelopmental impairment in very low birth weight infants[J]. J Perinatol, 2004, 24(12):763-768.
张国庆, 邵肖梅, 陆春梅. NICU 出院早产儿1 岁时神经发育 预后及干预依从性对其的影响[J]. 中国当代儿科杂志, 2007, 9(3):193-197.
[5]
Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial:benefits may vary in subgroups[J]. J Pediatr, 2010, 156(3):382-387.
[6]
Mueni E, Opiyo N, English M. Caffeine for the management of apnea in preterm infants[J]. Int Health, 2009, 1(2):190-195.
[7]
Fredholm BB, Battig K, Holman J, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use[J]. Pharmacol Rev, 1999, 51(1):83-133.
[8]
Gannon BA. Theophylline or caffeine:which is best for apnea of prematurity[J]. Neonatal Netw, 2000, 19(8):33-36.
[9]
Clark RH, Bloom BT, Spitzer AR, et a1. Reported medication use in the neonatal intensive care unit:data from a large national data set[J]. Pediatrics, 2006, 117(6):1979-1987.
[10]
Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants[J]. Cochrane Database Syst Rev, 2003, (1):CD000139.
[11]
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity[J]. N Engl J Med, 2006, 354(20):2112-2121.
[12]
Gray PH, Flenady VJ, Charles BG, et al. Caffeine citrate for very preterm infants:effects on development, temperament and behaviour[J]. J Paediatr Child Health, 2011, 47(4):167-172.
